
Sign up to save your podcasts
Or


Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial
By JAMA Network4.3
106106 ratings
Interview with Alex C. Spyropoulos, author of Efficacy and Safety of Therapeutic-Dose Heparin vs Standard Prophylactic or Intermediate-Dose Heparins for Thromboprophylaxis in High-risk Hospitalized Patients With COVID-19: The HEP-COVID Randomized Clinical Trial

135 Listeners

318 Listeners

2,057 Listeners

128 Listeners

497 Listeners

162 Listeners

886 Listeners

229 Listeners

3,339 Listeners

38 Listeners

21 Listeners

13 Listeners

11 Listeners

8 Listeners

16 Listeners

18 Listeners

5 Listeners

6 Listeners

30 Listeners

195 Listeners

9 Listeners

85 Listeners

14 Listeners

5 Listeners

5 Listeners

430 Listeners

8,188 Listeners

625 Listeners

263 Listeners

19 Listeners

237 Listeners

3 Listeners

48 Listeners